A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis 01

NCT03285308 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

336

Enrollment

INDUSTRY

Sponsor class

Stopped The Relamorelin program is being terminated solely based on a business decision.

Conditions

Gastroparesis
Diabetes Mellitus

Interventions

DRUG: Placebo
DRUG: Relamorelin

Sponsor

Allergan